SEC Form 4 · accession 0001104659-15-052162
CATABASIS PHARMACEUTICALS INC · CATB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jill C. Milne
Officer — President and CEO · Director
Period of report
Jul 17, 2015
Accepted (ET)
Jul 21, 2015 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001454789
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $14.05 | Jul 17, 2015 | A | 160,000 | A | — | Jul 16, 2025 | Common Stock | 160,000 | 160,000 | D |
Explanation of responses
- F1This option was granted on July 17, 2015 and vests over four years, with 25% of the shares vesting on the first anniversary of July 8, 2015 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.